Paenibacterin: Difference between revisions
CSV import |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 30: | Line 30: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
<gallery> | |||
File:Paenibacterin.svg|Paenibacterin | |||
</gallery> | |||
Latest revision as of 00:56, 17 March 2025
Paenibacterin is a bacteriocin produced by the bacteria Paenibacillus polymyxa. It is a broad-spectrum antibiotic that is effective against a variety of Gram-positive bacteria and Gram-negative bacteria.
Structure and Function[edit]
Paenibacterin is a non-ribosomally synthesized peptide with a unique structure. It contains a 14-membered macrocyclic lactone ring and a rare amino acid, 3-hydroxy-7-mercaptoheptanoic acid. This unique structure contributes to its broad-spectrum antibiotic activity.
The function of paenibacterin is to inhibit the growth of competing bacteria. It does this by disrupting the integrity of the bacterial cell membrane, leading to cell death.
Production and Isolation[edit]
Paenibacterin is produced by Paenibacillus polymyxa during the stationary phase of growth. It can be isolated from the culture supernatant by solvent extraction, followed by purification using high-performance liquid chromatography (HPLC).
Applications[edit]
Due to its broad-spectrum antibiotic activity, paenibacterin has potential applications in the treatment of various bacterial infections. It could also be used in the agriculture industry to control bacterial diseases in crops.
Research and Development[edit]
Research is ongoing to fully understand the mechanism of action of paenibacterin and to explore its potential applications. There is also interest in developing methods to produce paenibacterin on a large scale for commercial use.
See Also[edit]
-
Paenibacterin
